| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/13/2000 | WO2000020456A1 Novel g protein-coupled receptor protein and dna thereof |
| 04/13/2000 | WO2000020455A1 Novel g protein-coupled receptor protein and dna thereof |
| 04/13/2000 | WO2000020454A1 Methods and materials for detection and measurement of free radical damage |
| 04/13/2000 | WO2000020453A1 Chemical structure with affinity for a phospholipid, and marker compound, diagnosis kit, and medicine comprising said structure |
| 04/13/2000 | WO2000020452A2 Hypersensitive response elicitor fragments which are active but do not elicit a hypersensitive response |
| 04/13/2000 | WO2000020451A2 Anti-mitotic agents and processes |
| 04/13/2000 | WO2000020450A2 Calcium channel alpha-2/delta gene |
| 04/13/2000 | WO2000020449A2 MODIFIED TGF-β SUPERFAMILY PROTEINS |
| 04/13/2000 | WO2000020448A2 Nlk1 -interacting proteins |
| 04/13/2000 | WO2000020447A2 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses |
| 04/13/2000 | WO2000020446A2 Bax-mediated apoptosis modulating reagents and methods |
| 04/13/2000 | WO2000020445A2 Tumor antigens and ctl clones isolated by a novel procedure |
| 04/13/2000 | WO2000020444A1 Novel peptides |
| 04/13/2000 | WO2000020443A1 Novel peptides |
| 04/13/2000 | WO2000020438A1 G protein-coupled receptor resembling the thrombin receptor |
| 04/13/2000 | WO2000020434A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 04/13/2000 | WO2000020041A2 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent |
| 04/13/2000 | WO2000020037A1 A novel component in the hedgehog signalling pathway |
| 04/13/2000 | WO2000020031A1 Methods for identification, diagnosis, and treatment of breast cancer |
| 04/13/2000 | WO2000020030A1 Anti-inflammatory alpha2, beta1 integrin-related substances or antibodies |
| 04/13/2000 | WO2000020027A2 Methods for therapeutic vaccination |
| 04/13/2000 | WO2000020021A1 Repair of larynx, trachea, and other fibrocartilaginous tissues |
| 04/13/2000 | WO2000020018A1 Kappa-a conopeptides and uses therefor |
| 04/13/2000 | WO2000020011A1 Isolated dna encoding human h3 histamine receptor |
| 04/13/2000 | WO2000019988A1 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF |
| 04/13/2000 | WO2000019883A2 Compositions and methods of disease diagnosis and therapy |
| 04/13/2000 | WO2000003028A3 Method for optimizing the production of adenovirus vectors |
| 04/13/2000 | WO2000003015A3 Human transport protein homologs |
| 04/13/2000 | WO2000003010A3 Protein secretion from bacteria having reduced expression of a product encoded by the dlt operon |
| 04/13/2000 | WO2000003003A3 Screening of neisserial vaccine candidates and vaccines against pathogenic neisseria |
| 04/13/2000 | WO2000002916A3 PEPTIDE COMPOSITIONS MIMICKING TGF-β ACTIVITY |
| 04/13/2000 | WO2000001831A3 Proteases fused with variants of streptomyces subtilisin inhibitor |
| 04/13/2000 | WO2000001813A3 Peptide inhibitors of androgen-independent activation of androgen receptor |
| 04/13/2000 | WO2000001408A3 Haemophilus parasuis vaccine and diagnostic |
| 04/13/2000 | WO2000000634A3 METHODS OF INHIBITING $i(HELICOBACTER PYLORI) |
| 04/13/2000 | WO2000000608A3 Immune system molecules |
| 04/13/2000 | WO2000000509A3 Peptides for inhibiting hpv e7 proteins |
| 04/13/2000 | WO2000000224A3 Method for transporting a molecular substance in predetermined areas of eucaryotic cells |
| 04/13/2000 | WO1999065924A3 Preparation and use of superior vaccines |
| 04/13/2000 | WO1999064576A3 Human genes differentially expressed in colon cancer |
| 04/13/2000 | WO1999063094A3 Nucleotide and protein sequences of gpr1 and methods based thereon |
| 04/13/2000 | WO1999063078A3 Retinal calcium channel (alpha)1f-subunit gene |
| 04/13/2000 | WO1999061616A3 DNA CODING FOR A Mg?2+/H+ OR Zn2+/H+¿ EXCHANGER AND TRANSGENIC PLANTS EXPRESSING SAME |
| 04/13/2000 | WO1999061072A3 Methods of inhibiting clot formation |
| 04/13/2000 | WO1999060110A3 Stable envelope proteins for retroviral, viral and liposome vectors and use in gene and drug therapy |
| 04/13/2000 | WO1999055875A3 VACCINES CONTAINING RECOMBINANT PILIN AGAINST NEISSERIA GONORRHOEAE OR $i(NEISSERIA MENINGITIDIS) |
| 04/13/2000 | WO1999055720A9 Targeted gene delivery to cells by filamentous bacteriophage |
| 04/13/2000 | WO1999050637A3 Isolated multimeric complexes useful in analysis of t cells, peptides useful in making the complexes, and uses thereof |
| 04/13/2000 | WO1999035241A9 Transgenic rabbit that expresses a functional human lipoprotein (a) |
| 04/13/2000 | DE19845420A1 Interzelluläre Ausbreitung rekombinanter DNA Intercellular propagation of recombinant DNA |
| 04/13/2000 | CA2657302A1 Modified tgf-.beta. superfamily proteins |
| 04/13/2000 | CA2653985A1 Cytochrome p450 monooxygenase and nadph cytochrome p450 oxidoreductase genes and proteins related to the omega hydroxylase complex of candida tropicalis and methods relating thereto |
| 04/13/2000 | CA2347120A1 Nlk1 -interacting proteins |
| 04/13/2000 | CA2346765A1 Compositions and methods of disease diagnosis and therapy |
| 04/13/2000 | CA2346497A1 Spodoptera frugiperda single cell suspension cell line in serum-free media, methods of producing and using |
| 04/13/2000 | CA2346496A1 Novel th2-specific molecules and uses thereof |
| 04/13/2000 | CA2346375A1 Method for the treatment of chemonucleolysis |
| 04/13/2000 | CA2346339A1 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage |
| 04/13/2000 | CA2346327A1 Hypersensitive response elicitor from xanthomonas campestris |
| 04/13/2000 | CA2346217A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 04/13/2000 | CA2346134A1 G protein-coupled receptor resembling the thrombin receptor |
| 04/13/2000 | CA2346070A1 Bax-mediated apoptosis modulating reagents and methods |
| 04/13/2000 | CA2346068A1 A novel lymphocyte population expressing intracellular mo2 |
| 04/13/2000 | CA2346048A1 Methods for identification, diagnosis, and treatment of breast cancer |
| 04/13/2000 | CA2345881A1 Bone marrow-derived serum proteins |
| 04/13/2000 | CA2345817A1 Novel methods for therapeutic vaccination |
| 04/13/2000 | CA2345615A1 Novel g protein-coupled receptor protein and dna thereof |
| 04/13/2000 | CA2345477A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation |
| 04/13/2000 | CA2345408A1 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent |
| 04/13/2000 | CA2345377A1 Novel secreted proteins and polynucleotides encoding them |
| 04/13/2000 | CA2345375A1 Chemical structure with affinity for a phospholipid, and marker compound, diagnosis kit, and medicine comprising said structure |
| 04/13/2000 | CA2345215A1 Fusions of scaffold proteins with random peptide libraries |
| 04/13/2000 | CA2345045A1 G-protein coupled receptor proteins |
| 04/13/2000 | CA2345023A1 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
| 04/13/2000 | CA2344995A1 Cancer associated antigens and uses therefor |
| 04/13/2000 | CA2344976A1 Novel g-protein-coupled receptor protein and its dna |
| 04/13/2000 | CA2344765A1 Novel peptides |
| 04/13/2000 | CA2344593A1 Hypersensitive response elicitor fragments which are active but do not elicit a hypersensitive response |
| 04/13/2000 | CA2344563A1 Methods and compositions for the diagnosis and therapy of prostate cancer |
| 04/13/2000 | CA2344552A1 Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6 |
| 04/13/2000 | CA2344551A1 P-conotoxin peptide |
| 04/13/2000 | CA2344459A1 Novel g protein-coupled receptor protein and dna thereof |
| 04/13/2000 | CA2344456A1 Ptans: testis specific proteins expressed in prostate cancer |
| 04/13/2000 | CA2344269A1 Therapeutically active proteins in plants |
| 04/13/2000 | CA2344266A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 04/13/2000 | CA2343698A1 Repair of larynx, trachea, and other fibrocartilaginous tissues |
| 04/13/2000 | CA2343651A1 Use of socs-2 or cis to screen for compounds enhancing growth hormone effect |
| 04/13/2000 | CA2342606A1 Thromboplastin reagents and methods for preparing and using such reagents |
| 04/13/2000 | CA2341351A1 Alpha-2/delta gene |
| 04/13/2000 | CA2340333A1 Crystals of the alpha 1 beta 1 integrin i-domain and their use |
| 04/13/2000 | CA2284850A1 Dna coding for protein which confers on bacterium escherichia coli resistance to l-homoserine, and method for producing l-amino acids |
| 04/12/2000 | EP0992588A1 DsbA/DsbB/DsbC/DsbD expression plasmid |
| 04/12/2000 | EP0992587A2 High affinity IP3-binding polypeptide |
| 04/12/2000 | EP0992586A2 Extracellular matrix proteins with modified amino acid |
| 04/12/2000 | EP0992585A2 Human calcium channel compositions and methods |
| 04/12/2000 | EP0992584A2 Purified mammalian FLT3 ligands and agonists and antagonists thereof |
| 04/12/2000 | EP0992582A2 Schistosoma recombinant fusion protein vaccine |
| 04/12/2000 | EP0992581A2 Immunodominant human T-cell epitopes of hepatitis C virus |
| 04/12/2000 | EP0992580A2 Immunodominant human T-cell epitopes of Hepatitis C virus |
| 04/12/2000 | EP0992579A1 Stem cell factor |